IDEXX Laboratories, Inc. (IDXX)
NASDAQ
Closed
Aug 24, 2026
Day's Range
554.2952 wk Range
518.55Overview - IDXX - IDEXX Laboratories, Inc.
Key Statistics
Valuation
Enterprise Value
44.77B
P/E (Trailing)
‪39.05‬
P/E (Forward)
‪33.27‬
PEG Ratio
‪2.26‬
Price / Sales (TTM)
‪9.63‬
Price / Book
‪27.24‬
EV / EBITDA
‪27.61‬
Profitability
Gross Margin
‪64.03%‬
Profit Margin
‪25.03%‬
Operating Margin
‪34.98%‬
Return on Assets
‪27.08%‬
Return on Equity
‪74.21%‬
Ownership
Shares Outstanding
78.87M
Float
78.50M
Short % of Shares Outstanding
‪2.79%‬
Held by Insiders
‪0.22%‬
Held by Institutions
‪96.82%‬
Price stats
Beta
‪1.54‬
50-Day Avg
‪560.00‬
200-Day Avg
‪615.10‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
14 analysts
Average price target
‪$ 698.92‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - IDXX - IDEXX Laboratories, Inc.
Peers - IDXX - IDEXX Laboratories, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
Profile Summary - IDXX - IDEXX Laboratories, Inc.
About
IDEXX Laboratories, Inc. is a healthcare diagnostics company specializing in products and services for the veterinary, livestock, poultry, dairy, and water testing markets. The company develops and manufactures diagnostic test kits, in-clinic analyzers, and reference laboratory services that support veterinarians in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
